TEMENOS
3.11.2020 10:02:06 CET | Business Wire | Press release
Temenos (SIX: TEMN), the banking software company, today announced that registration is open for Temenos SCALE on the 17-18 November 2020. Temenos SCALE is the biggest developer conference in the banking industry, attracting developers from over 106 countries and from every type and size of institution across the banking industry. At Temenos SCALE, this global developer community will experience hands-on workshops, presentations and demonstrations with a focus on Explainable AI, microservices and open APIs and cloud technologies. Register here for this free to attend event.
Paul Roberts, Director, Temenos Developer Community & MarketPlace, Temenos, said: “Developers love Temenos because we have the most advanced technology, the richest ecosystem and the largest customer base of the most ambitious and challenger banks. We recognize the vital role our developer community plays in shaping the future of banking and we are committed to developers’ success. We invest an industry leading 20 per cent of our revenues into research and development – a further $1bn investment over just the next few years. And we are making significant investment in our developers too, supporting them with the tools, skills and knowledge to use our technology to solve real world problems at scale. Our API-first technology and modern microservices-based architecture enables rapid innovation and our MarketPlace gives developers a shop window into banks serving more than one billion people around the world. Banking truly is the most exciting space for developers right now and Temenos SCALE is the flagship event to bring the developer community together, to learn, share and grow.”
Attendees of Temenos SCALE will hear from influential technology and banking industry leaders. Temenos CEO Max Chuard will keynote on why now is a pivotal moment in the banking industry, how developers are shaping the future and making banking a force for good and how Temenos is supporting them with innovative technologies to create and bring new products to market faster.
Banks face mounting pressure as they try to keep pace with evolving customer expectations, competition and changing regulations. Covid-19 has accelerated the shift to digital banking and SaaS; Open Banking regulation is splitting the value chain and proving a catalyst for innovation; and with the rise of big tech, customers now expect seamless, hyper-personalized experiences. These trends are driven and enabled by technology and banks increasingly need developers to help them survive and thrive in this digital-first era.
The Temenos SCALE event will include over 40 sessions, including hands-on workshops and product demonstrations. Attendees will also hear from Temenos’ technology partners and customers. ABN AMRO will share insights on the power of analytics, Openbank on the extensibility of Temenos Transact to differentiate and Canadian Western Bank on design thinking. The event is supported by IBM as the headline sponsor, Microsoft, Red Hat, TailWind, NuoDB and Syncordis,
Andre Tost, Distinguished Engineer and CTO, IBM Cloud Pak Architecture, said: “At Temenos SCALE, you’ll hear about how IBM and our business partner Temenos are working together to bring hybrid cloud solutions to banking, and deliver greater automation, innovation and integration capabilities to our joint clients. I hope you’ll join us as we explore the incredible advances of modern software and API-led technology built with IBM offerings, like LinuxONE and IBM Cloud Paks. We look forward to engaging the brightest minds in the developer community – today’s change leaders – to discuss how we can work together to create powerful change in the banking industry on a global scale.”
Follow #TemenosSCALE on social media for live updates on LinkedIn, Twitter, Facebook and Instagram.
– Ends –
About Temenos
Temenos AG (SIX: TEMN) is the world’s leader in banking software. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 500 million banking customers. Temenos offers cloud-native, cloud-agnostic and AI-driven front office, core banking, payments and fund administration software enabling banks to deliver frictionless, omnichannel customer experiences and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve cost-income ratios of 26.8% half the industry average and returns on equity of 29%, three times the industry average. These clients also invest 51% of their IT budget on growth and innovation versus maintenance, which is double the industry average, proving the banks’ IT investment is adding tangible value to their business.
For more information, please visit www.temenos.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201103005032/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom